DrugDashboards

Methylprednisolone Sodium Succinate

Methylprednisolone · METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mL · Injection, Powder, Lyophilized, For Solution · Intramuscular; Intravenous · Amneal Pharmaceuticals LLC

NDC 70121-1001-05 · 25 VIAL in 1 CARTON / 2 mL in 1 VIAL · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$212.55
Reported to Texas DSHS · 2025 annual filing · Amneal Pharmaceuticals LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2024)

$157
41 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $7.14 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA207549
TE code
AP
Approval date
Nov 9, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Methylprednisolone (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
Tianjin Kingyork Pharmaceuticals Co., LtdMETHYLPREDNISOLONE SODIUM SUCCINATE 1 g/16mLJul 15, 2026Sep 2, 2026
Tianjin Kingyork Pharmaceuticals Co., LtdMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
Tianjin Kingyork Pharmaceuticals Co., LtdMETHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/8mLJul 15, 2026Sep 2, 2026
Tianjin Kingyork Pharmaceuticals Co., LtdMETHYLPREDNISOLONE SODIUM SUCCINATE 2 g/30.6mLJul 15, 2026Sep 2, 2026
Tianjin Kingyork Pharmaceuticals Co., LtdMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Methylprednisolone Sodium Succinate — NDC 70121-1001-05," retrieved September 3, 2026, https://drugdashboards.com/drug/70121100105.

Free to cite with attribution — see how the data is put together.